Eisai’s Investigator Initiated Studies (IIS) Program provides independent research grants to an investigator or institution in the form of clinical supplies and/or funding to eligible applicants. IIS research grants must support scientifically compelling and innovative studies that are consistent with Eisai’s strategic research goals and therapeutic areas of focus and must address legitimate medical or scientific questions.
Detailed submission policies and procedures are posted on this website for your use. If you have any questions regarding the preparation of the application, or are experiencing technical difficulties, please contact the Eisai Grants Department:
Please allow 1 business day for return reply.
Please click the following link to learn about Eisai’s current areas of research interest. All Investigator Initiated Study (IIS) application requests and proposals must be in compliance with Eisai's policies and procedures in the categories and for the Eisai marketed products and investigational compounds described on the website and must be in compliance with all applicable governmental regulations and Eisai policies and procedures.
Eisai provides support in the form of funding and/or drug supply to eligible applicants to support scientifically compelling and innovative research consistent with Eisai’s therapeutic or clinical interests and to address legitimate medical or scientific questions impacting/relating to the use of Eisai marketed products or investigational compounds.
Please complete your application using our online templates located in the Documents and Resources tab. Please feel free to Contact us if you have any questions regarding the submission or review process.
The IIS Committee is comprised of Eisai Clinical, Medical, Legal, Regulatory, Safety, and Statistics personnel. The Committee will review your application and proposal. Funding and/or drug supplies are provided based on scientific merit and consistency with Eisai’s scientific areas of interest.
The IIS Committee meets regularly to review and discuss proposals. Completed applications must be submitted at least 2 weeks prior to the next scheduled IIS Committee meeting date. In general, you should expect to receive an email communication within one week following the IIS Committee meeting. If you have questions regarding the status of your proposal, you may contact us by phone (866-434-8176) or email (firstname.lastname@example.org) for assistance.
In order to ensure a complete and timely review, we ask that you please include all fields on the Eisai application form along with the Eisai budget template, if applicable.
Applicant completes the Following and submits all documents to the IIS in-box: email@example.com
To begin your oncology IIS grant application, please click the link below to be directed to the Eisai Oncology IIS VisionTracker portal for preparation and submission of an electronic application. You will be prompted to create a user login and password. Please note that your user name will be your email address.
The following documents will need to be attached in the designated fields or attachment section of the system:
If you are requesting support in the form of funding, please utilize our online template.